BARD1 Life Sciences - Investor Presentation (ASX:IIQ) 23 Jul, 2021 11:45 AM To view the presentation, download the attached PDF.
BARD1 Life Sciences - Appendix 3B (ASX:IIQ) 23 Jul, 2021 11:40 AM To view the Proposed issue of +securities, download the attached PDF.
BARD1 Life Sciences $15m Placement to Accelerate Cancer Diagnostic Program (ASX:IIQ) 23 Jul, 2021 11:39 AM BARD1 completes $15 million placement with strong demand from new and existing institutional and sophisticated investors in Australia and Hong Kong Proceeds will be used primarily to fund develo...read more
BARD1 Life Sciences - Trading Halt (ASX:IIQ) 21 Jul, 2021 08:27 AM The securities of BARD1 Life Sciences Limited (‘BD1’) will be placed in trading halt at the request of BD1, pending it releasing an announcement. Unless ASX decides otherwise, the securi...read more
BARD1 Investor Presentation (ASX:IIQ) 07 Jul, 2021 09:46 AM To view the presentation, download the attached PDF.
BARD1 Life Sciences Autoantibody Test Results for Ovarian Cancer Published (ASX:IIQ) 29 Jun, 2021 08:21 AM -- Studies performed at the University of Geneva in 2018 for the Company’s BARD1 autoantibody (AAb) test for detection of ovarian cancer published in international peer-reviewed journal Genes ...read more
